Follicum
Tore Duvold is a seasoned leader with extensive experience in the biopharmaceutical and healthcare sectors. Currently serving as the Chief Executive Officer of Roto Health ApS and Spermosens AB, Tore Duvold is dedicated to advancing innovative diagnostic and treatment solutions for infertility. Previous roles include Chief Executive Officer at Coegin Pharma AB, contributing to the development of novel treatments for various conditions, and Senior Vice President at LEO Pharma, overseeing drug discovery and clinical development in dermatology. Tore Duvold has also held executive positions at Aker BioPharma AS and Innovation Fund Denmark, where significant contributions were made in research funding and innovation. Academic credentials include a Ph.D. in Bioorganic Chemistry from the University of Strasbourg and leadership training from IMD and INSEAD.
This person is not in any offices